Abstract
Obesity as a pathogenic disorder is a predisposing factor for cardiovascular diseases and shows an increasing incidence in the industrialized countries. Adipokines such as leptin, adiponectin and resistin have a great impact on the development of atherosclerosis in obesity. Elevated levels of leptin have been found to be atherogenic whereas decreased levels of adiponectin have been proved to be anti-atherogenic in recent studies. The exact role of resistin in the process of atherosclerosis has so far remained uncertain and controversial. In our recent work, we studied the alteration in human paraoxonase-1 (PON1) activity and adipokine levels; furthermore, we also aimed at identifying the potential correlation between these parameters in this metabolic disorder. We investigated the above-mentioned parameters both in adults and in children, with regard to the emerging role of childhood obesity and to get a clearer view of these factors during a whole lifetime. Investigating the adult population with a broad range of body mass index (BMI) we found significantly increased leptin and significantly decreased adiponectin and resistin levels and PON1 activity in the obese group compared to the lean controls. Adiponectin and resistin levels showed significantly positive correlation, while leptin and BMI showed significantly negative correlation with PON1 activity.
Our findings were similar in childhood obesity: leptin showed significantly negative correlation, while adiponectin showed significantly positive correlation with PON1 activity. We found gender differences in the univariate correlations of leptin and adiponectin levels with PON1 activity in the adult population. In multiple regression analysis, adiponectin proved to be an independent factor of PON1 activity both in childhood and adult obesity, furthermore thiobarbituric acid-reactive substances (TBARS) also proved to be an independent predictor of the enzyme in adults, reflecting the important role of oxidative stress in obesity. Investigating PON 192 Q/R polymorphism by phenotypic distribution (A/B isoenzyme) in obese children, we found a significant correlation of PON1 arylesterase activity with leptin and adiponectin levels, and of body fat percentage with PON1 192 B isoenzyme.
According to our studies, these metabolic changes in obesity predispose to the early development of atherosclerosis throughout our whole lifetime. Decreased activity of PON1 and alterations in adipokine levels in childhood obesity could contribute to an early commencement of this process, detected only later in adulthood by increased cardiovascular morbidity and mortality. Changed levels of leptin, adiponectin, resistin and PON1 activity at all ages, just like 192 Q/R polymorphism determined by phenotypic distribution, may be useful markers beside the general risk factors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bajnok L, Seres I, Varga Z et al. (2007) Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals. Metabolism 56:1542–1549
Bajnok L, Csongradi E, Seres I et al. (2008a) Relationship of adiponectin to serum paraoxonase-1. Atherosclerosis. 197:363–367
Bajnok L, Seres I, Varga Z et al. (2008b) Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index. Exp Clin Endocrinol Diabetes 116:592–599
Beltowski J, Wójcicka G, Jamroz A (2003) Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 170:21–29
Beltowski J (2005) Protein homocysteinylation: a new mechanism of atherogenesis? Postepy Hig Med Dosw 59:392–404
Beltowski J. (2006) Leptin and atherosclerosis. Atherosclerosis 189:47–60
Beltowski J, Jamroz-Wiśniewska A and Widomska S (2008) Adiponectin and its role in cardiovascular diseases. Cardiovasc Hematol Disord Drug Targets 8:7–46
Bouloumie A, Marumo T, Lafontan M et al. (1999) Leptin induces oxidative stress in human endothelial cells. FASEB J 13:1231–1238
Curat CA, Miranville A, Sengenès C et al. (2004) From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53:1285–1292
Díez JJ and Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293–300
Dubey L and Hersong Z (2006) Role of leptin in atherogenesis. Exp Clin Cardiol 11:269–275
Ferré N, Marsillach J, Camps J et al. (2006) Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J Hepatol 45:51–59
Ferretti G, Bacchetti T, Moroni C et al. (2005) Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 90:1728–1733
Ford ES (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769–1778
Ho RC, Davy K, Davy B et al. (2002) Whole-body insulin sensitivity, low-density lipoprotein (LDL) particle size, and oxidized LDL in overweight, nondiabetic men. Metabolism 51:1478–1483
Holvoet P, Mertens A, Verhamme P et al. (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21:844–848
Holvoet P (2006) Obesity, the metabolic syndrome, and oxidized LDL. Am J Clin Nutr 83:1438
Hotta K, Funahashi T, Arita Y et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, Arterioscler Thromb Vasc Biol 20:1595–1599
Katagiri H, Yamada T and Oka Y (2007) Adiposity and cardiovascular disorders. Disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101:27–39
Kumada M, Kihara S, Sumitsuji S et al. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85–89
Mackness MI, Durrington PN (1995) Paraoxonase: another factor in NIDDM cardiovascular disease. Lancet 346:856
Mackness MI, Durrington PN, Mackness B (2004) The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 4:211–217
Matsuda M, Shimomura I, Sata M et al. (2002) Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J Biol Chem 277:37487–37491
Meier U and Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50:1511–1525
Mutlu-Turkoglu U, Oztezcan S, Telci A et al. (2003) An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med 2:171–174
Paragh Gy, Seres I, Balogh Z et al. (1998) The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron 80:166–170
Paragh Gy, Asztalos L, Seres I et al. (1999) Serum paraoxonase activity changes in uremic and kidney transplanted patients. Nephron 83:126–131
Paragh G, Töröcsik D, Seres I et al. (2004) Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia. Curr Med Res Opin 20:1321–1327
Patel SB, Reams GP, Spear RM et al. (2008) Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep 10:131–137
Rabe K, Lehrke M, Parhofer KG et al. (2008) Adipokines and insulin resistance. Mol Med 14:741–751
Rosenson RS (2006) Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy. Am Heart J 151:556–563
Seres I, Paragh Gy, Deschene E et al. (2004) Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 39:56–66
Shimabukuro M, Higa N, Asahi T et al. (2003) Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88:3236–3240
Sjogren P, Basu S, Rosell M et al. (2005) Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol 25:2580–2586
Sutherland W, Manning PJ, de Jong SA et al. (2001) Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women. Metabolism 50:319–324
Szmitko PE, Teoh H, Stewart DJ et al. (2007) Adiponectin and cardiovascular disease: state of the art Am J Physiol Heart Circ Physiol 292:1655–1663
Tomás M, Sentí M, García-Faria F et al. (2000) Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 20:2113–2119
Uzun H, Zengin K, Taskin M et al. (2004) Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 14:659–665
Varga Z, Paragh G, Seres I et al. (2006) Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients. Nephron Clin Pract 103:114–120
Wannamethee SG, Tchernova J, Whincup P et al. (2007) Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 191:418–426
Weinbrenner T, Schröder H, Escurriol V et al. (2006) Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr 83:30–35
Acknowledgments
This work was supported by a grant from the Hungarian Scientific Research Fund (OTKA K63025), ETT (Medical Research Council) (243/2006) and Hungarian National Office for Research and Technology (OMFB-1613/2006), Hungary.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this paper
Cite this paper
Seres, I., Bajnok, L., Harangi, M., Sztanek, F., Koncsos, P., Paragh, G. (2010). Alteration of PON1 Activity in Adult and Childhood Obesity and Its Relation to Adipokine Levels. In: Reddy, S. (eds) Paraoxonases in Inflammation, Infection, and Toxicology. Advances in Experimental Medicine and Biology, vol 660. Humana Press. https://doi.org/10.1007/978-1-60761-350-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-60761-350-3_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-349-7
Online ISBN: 978-1-60761-350-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)